ZAIN I MEMON

Allopathic & Osteopathic Physicians|Internal Medicine FOREST HILLS, NY NPI 1679004154

General Payments — all program years on this page

$1,675.82

  • Category: General Payments
  • Program years: PY2020–2024
  • Record count: 85
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $408.69 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $408.6921

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2020 $113.646
2021 $452.7623
2022 $371.8018
2023 $328.9317
2024 $408.6921

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1089456156 Daiichi Sankyo Inc. $17.08 01/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097426556 Novo Nordisk Inc $32.84 11/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097703720 Novo Nordisk Inc $17.02 02/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097736059 Novo Nordisk Inc $24.50 08/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104279781 AstraZeneca Pharmaceuticals LP $14.04 05/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104516248 AstraZeneca Pharmaceuticals LP $20.26 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105299120 AstraZeneca Pharmaceuticals LP $14.39 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114466355 Exact Sciences Corporation $13.30 02/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114466360 Exact Sciences Corporation $20.31 10/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131451695 PFIZER INC. $26.45 01/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131541102 PFIZER INC. $25.89 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133637549 Gilead Sciences, Inc. $19.18 07/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135477722 Lilly USA, LLC $21.59 04/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135521103 Lilly USA, LLC $24.11 07/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137634734 Takeda Pharmaceuticals U.S.A., Inc. $13.13 03/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137634736 Takeda Pharmaceuticals U.S.A., Inc. $24.23 04/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137634738 Takeda Pharmaceuticals U.S.A., Inc. $17.77 05/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141909940 Merck Sharp & Dohme LLC $14.82 06/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147729476 QOL Medical, LLC $13.25 02/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150132655 SHIELD THERAPEUTICS INC $16.71 05/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151096253 Phathom Pharmaceuticals, Inc. $17.82 04/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.